Trinity Biotech (TRIB) Other Gross PP&E Adjustments (2009 - 2025)

Trinity Biotech has disclosed Other Gross PP&E Adjustments across 17 years of filings, most recently posting $4.3 million for Q2 2025.

• Other Gross PP&E Adjustments for Q2 2025 came in at $4.3 million, up 10.32% year-over-year; the trailing twelve-month figure through Jun 2025 was $4.3 million (up 10.32% YoY), and the FY2024 annual result was $4.6 million, up 144.24% from the prior year.
• Other Gross PP&E Adjustments came in at $4.3 million for Q2 2025 at Trinity Biotech, down from $4.6 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $8.6 million in Q1 2021 to a low of $1.8 million in Q3 2023.
• The 5-year median for Other Gross PP&E Adjustments is $5.5 million (2023), against an average of $4.8 million.
• Across the five-year window, Other Gross PP&E Adjustments slumped 70.34% in 2023 and surged 144.24% in 2024, its largest moves.
• Trinity Biotech's Other Gross PP&E Adjustments stood at $5.9 million in 2021, then decreased by 3.99% to $5.7 million in 2022, then slumped by 66.7% to $1.9 million in 2023, then jumped by 144.24% to $4.6 million in 2024, then dropped by 6.75% to $4.3 million in 2025.
• The last three Other Gross PP&E Adjustments figures came in at $4.3 million (Q2 2025), $4.6 million (Q4 2024), and $3.8 million (Q3 2024), per Business Quant data.